Pulsenmore Rockets Higher as Ouma Health Deal Brings Home Ultrasound to Virtual Maternity Care
Pulsenmore (NASDAQ: PLSM) just went vertical after finally landing the kind of U.S. commercial partner its story has been missing. The stock jumped more than 200% after Ouma Health chose Pulsenmore’s at‑home pregnancy ultrasound system for its virtual maternity care offering.
What Pulsenmore Announced
Ouma plans to integrate Pulsenmore’s FDA‑cleared home ultrasound device so expectant mothers can perform scans at home, with clinicians reviewing the images remotely as part of routine virtual care. That shifts Pulsenmore’s technology from a niche standalone product into a tool embedded inside a scaled maternity care network, with particular relevance for patients in remote or underserved areas.
Why It Matters for Investors
For investors, this is less about a one‑day meme move and more about Pulsenmore finally securing a credible U.S. distribution channel. The market is effectively front‑running the revenue story that could follow if Ouma rolls the solution out widely and payers come on board, though the lack of disclosed deal terms and the stock’s thin float mean volatility and sharp pullbacks are very likely from here.
